CVEvulnerability

CVE-2026-105704

5.5 MEDIUM Published 2026-10-06 Modified 2026-10-06 Official page ↗
Status
Deferred
Published
2026-10-06
Last modified
2026-10-06
Assigner
[email protected]
CVSS 4.0 ([email protected])
5.5 MEDIUM — CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
CVSS 3.1 ([email protected])
7.3 HIGH — CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
CVSS 2.0 ([email protected])
7.5 HIGH — AV:N/AC:L/Au:N/C:P/I:P/A:P
Weaknesses
CWE-287

Description

A vulnerability was identified in SourceCodester Drug Recommendation System 1.0. This affects an unknown function of the component Auth Guard. Such manipulation of the argument user_id leads to improper authentication. The attack can be executed remotely. The exploit is publicly available and might be used.

Related

Weakness · CWE (1)

  • CWE-287 Improper Authentication weakness

References